Boaz Nachmias
17PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (17)
Sort by Publication Date:
|Aug 31, 2025
Measurable residual disease-guided therapy in acute myeloid leukaemia: Practical insights.Boaz Nachmias, Arnon Haran, Meira Yisraeli Salman
|Dec 31, 2024
Post-Relapse Outcomes of Older Patients With NPM1-Mutated AML Are Favorable With Allo Transplant in Second Remission.Avraham Frisch, Chezi Ganzel, Yishai Ofran
|Dec 05, 2024
Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study.Ofir Wolach, Itai Levi, Boaz Nachmias
|Jan 31, 2024
Venetoclax resistance in acute myeloid leukaemia-Clinical and biological insights.Boaz Nachmias, Shlomzion Aumann, Arnon Haran
|Nov 25, 2023
Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of Interest.Boaz Nachmias, Svetlana Krichevsky, Moshe E Gatt
|Sep 28, 2023
Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Modulate Apoptosis, TNF Alpha and Interferon Gamma Response Gene mRNA Expression in T Lymphocytes.Andrea Fracchia, Drirh Khare, Samar Da'na
Pageof 3
Frequent Collaborators
4 joint publications
Adir Shaulov
4 joint publications
Aaron D Schimmer
3 joint publications
Chezi Ganzel
2 joint publications
Ofir Wolach
2 joint publications
Gary D Bader
2 joint publications
Yishai Ofran
2 joint publications
Batia Avni
2 joint publications
Moshe E Gatt
1 joint publications
Jonathan St-Germain
1 joint publications
Mark D Minden
